TLX Telix Pharmaceuticals Ltd
Nasdaq · SEC CIK 2007191 · EDGAR
- Bought, last 12 months
- $1.02M 2 purchases by 2 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 3 since 2026-04-01, latest 2026-09-14 19:20
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Behrenbruch Christian | MD, Group CEO, Dir | $996.7K | — |
| Smith Darren Charlton | Group CFO | $20.0K | — |
Transactions 3
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 19:20 | 2026-09-07 | TLX | Smith Darren Charlton | Group CFO | P - Purchase | $9.66 | +2,071 | 14.0K | +17% | +$20.0K | |
| MI | 2026-05-06 21:32 | 2026-04-28+ | TLX | Behrenbruch Christian | MD, Group CEO, Dir | P - Purchase | $14.67 | +67.9K | 20.74M | +0.3% | +$996.7K |
| D | 2026-04-01 19:14 | 2026-03-29 | TLX | Smith Darren Charlton | Group CFO | M - OptEx | $0.00 | +1,111 | 11.9K | +10% | $0 |
Purchase Sale Sale after option exercise All abbreviations